Objective
To evaluate the clinical significance of telomerase activity, particularly
in terms of prognostic impact, in non-small cell lung cancer (NSCLC).
Summary Background Data
Telomerase activity has been found in Various tissues. The activation of te
lomerase is considered necessary for the immortalization of human tumor cel
ls, including NSCLC.
Methods
The authors studied 103 NSCLC specimens using a polymerase chain reaction b
ased on a telomeric repeat amplification protocol assay.
Results
Telomerase activity was detected in 85 (82.5%) of 103 NSCLC specimens but i
n none of the paired normal lung tissue specimens. More cases of positive t
elomerase activity were observed in the group with advanced disease and in
the group with poorly differentiated tumors. Such factors as the mean age a
t surgery, sex, smoking, histologic type, and size of tumor extension did n
ot correlate with the telomerase activity. The Kaplan-Meier survival curves
in all patients with NSCLC demonstrated that patients with telomerase-posi
tive tumors survived for a significantly shorter period than those with a t
elomerase-negative tumor (p = 0.0058). According to a multivariate analysis
, telomerase activity was identified as an independent prognostic factor (R
R = 8.62, p = 0.035).
Conclusions
Telomerase activity was one of the most important prognostic factors in pat
ients with NSCLC, and its potential prognostic implication was independent
of tumor stage.